JAN 09, 2020 11:52 AM PST

Can Cancer Drugs Treat Lung Damage?

WRITTEN BY: Nouran Amin

Can therapeutics used in the treatment of cancer be a breakthrough for pulmonary disease? Specifically, chronic obstructive pulmonary disease (COPD)? “COPD is usually treated with steroids and airway muscle relaxants which ease symptoms, but there is currently no effective treatment clinically available to counteract the damage it does to the lungs,” says Dr. Lynne Prince, Russell Fellow at the University of Sheffield.

Learn more about COPD:

Individuals with COPD experience a wide range of symptoms that affect overall quality of life such as shortness of breath and chest infections.

However, these symptoms are driven by the damage that occurs to the lungs caused by a particular cell type found in our immune system—the neutrophils.

Now, researchers at the University of Sheffield have screened a library of cancer drugs to identify particles that accelerate the death of neutrophils and encourage healing in the lungs. “Our research now shows that inhibitors of these cell signaling processes, or ErbB kinases, could have therapeutic potential in neutrophilic inflammatory disease,” says Prince. “The hope of these drugs is that they can clear the damaging cells from the lungs of people living with COPD, preventing any further damage and therefore the progression of the disease for the first time.”

The goal is these drugs are repurposed to treat COPD by clearing the damage caused by the neutrophils and therefore, delaying the progression of the disease.

“We are in desperate need of a new treatment for COPD, millions of people all over the world live with the disease and it has a massive impact on their quality of life, especially as the disease progresses,” says Professor Stephen Renshaw on the clinical benefits of drug repurposing. “What is exciting about this research is that these drug compounds are available now, which means if our continued research can effectively find a lead compound to benefit people living with COPD, they are ready to use.

Source: University of Sheffield

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
FEB 18, 2021
Drug Discovery & Development
Weight-Loss Hormone Prevents Muscle-Loss
FEB 18, 2021
Weight-Loss Hormone Prevents Muscle-Loss
Scientists from the University of Southern California Leonard Davis School of Gerontology, show that a hormone known to ...
MAR 15, 2021
Cell & Molecular Biology
When Sample Temperature Matters: How to Keep Your Cool in the Lab
MAR 15, 2021
When Sample Temperature Matters: How to Keep Your Cool in the Lab
Temperature control is critical to many molecular and cellular experiments, but managing sample temperature requires eit ...
MAR 03, 2021
Drug Discovery & Development
Keeping HIV Latent
MAR 03, 2021
Keeping HIV Latent
When (HIV) human immunodeficiency virus infects cells, it can go to sleep as opposed to make viral copies of itself&mdas ...
APR 17, 2021
Drug Discovery & Development
Facebook AI May Speed up Cancer Drug Discovery
APR 17, 2021
Facebook AI May Speed up Cancer Drug Discovery
Facebook has claimed that its new artificial intelligence, known as 'Compositional Perturbation Autoencoder' (CP ...
APR 24, 2021
Drug Discovery & Development
Lithium Treats Intellectual Disabilities in Mice
APR 24, 2021
Lithium Treats Intellectual Disabilities in Mice
Mouse models of Bardet-Biedl Syndrome (BBS) have a challenge with learning as a result of dysfunctional neuronal systems ...
MAY 04, 2021
Health & Medicine
Micro-dosing Inhaler Breakthrough for Medical Cannabis
MAY 04, 2021
Micro-dosing Inhaler Breakthrough for Medical Cannabis
In a leap that will eliminate the risks of vaping or smoking, Canada has just approved an Israeli-made inhaler that is a ...
Loading Comments...